Potential treatment for nonalcoholic fatty liver disease
Inhibiting a nuclear receptor in the gut could lead to a treatment for a liver disorder that affects almost 30 percent of the Western world's adult population, according to an international team of...
Cancer can't grow if cells can't move
By blocking a widespread enzyme, Centenary researchers have shown they can slow down the movement of cells and potentially stop tumours from spreading and growing.
Research rules out Hepatitis C as cause of mental impairment in HIV patients
Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer.
Study compares effectiveness of antiviral drugs to prevent hepatitis B virus-related hepatitis among patients receiving chemotherapy for lymphoma
Among patients with lymphoma undergoing a certain type of chemotherapy, receiving the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV...
Hotspots identified in deaths from HIV/AIDS and Hepatitis C in Massachusetts
A new study from epidemiologists at Tufts University School of Medicine helps to identify communities with the greatest public health need in Massachusetts for resources relating to HIV/AIDS and...
Adherence to drug regimen by liver transplant patients hindered by limited literacy, more meds
New research reports that liver transplant recipients with less understanding of treatment information and improper use of medications may be more likely to have trouble following the prescribed...
Added benefit not proven for treating hepatitis C with daclatasvir
Data were lacking or unsuitable for research questionThe drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC)...
Scaling up screening for viral hepatitis in Europe: the HEPscreen toolkit shows what works
A new toolkit on screening for chronic viral hepatitis seeks to raise awareness, improve knowledge and motivate public health professionals in Europe to take action.
Liver disease in Europe: new study reveals pressing need to focus on research and policy action
In an event hosted on 10 December by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) launched the 'Research Roadmap for Liver...
Tumor microenvironment of hepatitis B virus-associated hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the few cancers in which a continued increase in incidence has been observed over recent years.